Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2005The Journal of ImmunologyOpen Access

Anti-CD25 Antibody Enhancement of Vaccine-Induced Immunogenicity: Increased Durable Cellular Immunity with Reduced Immunodominance

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAnne MooreUniversity College CorkAGAwen GallimoreCardiff UniversitySDSimon J. DraperUniversity of Oxford

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moore et al. (2005) studied this question.

synapsesocial.com/papers/6a9154c29cd0eb66ad33f8a2https://doi.org/10.4049/jimmunol.175.11.7264
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A<i>Plasmodium falciparum</i>candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses2003 · 60 citations
  2. 2IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES1999 · 951 citations
  3. 3CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination2003 · 191 citations
  4. 4Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific2000 · 1,239 citations
  5. 5Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials2003 · 140 citations